Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8DYX3
|
|||
| Drug Name |
NLS-001
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 2 | [1] | |
| Company |
NLS Pharmaceutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of NLS Pharmaceutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.